COO of Kala Pharmaceuticals Inc (30-Year Financial, Insider Trades) Todd Bazemore (insider trades) bought 10,000 shares of KALA on 03/16/2020 at an average price of $5.75 a share. The total cost of this purchase was $57,500.
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases. Kala Pharmaceuticals Inc has a market cap of $259.970 million; its shares were traded at around $6.74 with and P/S ratio of 37.86. GuruFocus has detected 2 severe warning signs with Kala Pharmaceuticals Inc. .
Directors and Officers Recent Trades:
- COO Todd Bazemore bought 10,000 shares of KALA stock on 03/16/2020 at the average price of $5.75. The price of the stock has increased by 17.22% since.
- Director Gregory Grunberg bought 2,534,854 shares of KALA stock on 03/13/2020 at the average price of $7.89. The price of the stock has decreased by 14.58% since.
- Director, 10% Owner Rajeev M. Shah bought 6,337,135 shares of KALA stock on 03/13/2020 at the average price of $7.89. The price of the stock has decreased by 14.58% since.
- Director, 10% Owner Capital Healthcare Fund Lp Ra bought 6,337,135 shares of KALA stock on 03/13/2020 at the average price of $7.89. The price of the stock has decreased by 14.58% since.
For the complete insider trading history of KALA, click here
.
